Efficacy and tolerability of lasmiditan, an oral 5-HT1F receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study
Titel:
Efficacy and tolerability of lasmiditan, an oral 5-HT1F receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study
Auteur:
Färkkilä, Markus Diener, Hans-Christoph Géraud, Gilles Láinez, Miguel Schoenen, Jean Harner, Nadja Pilgrim, Alison Reuter, Uwe